PRECISIONadvisors
Scott Rubin is a Vice President at PRECISIONadvisors since March 2021, where the focus is on delivering analytics-based solutions for commercialization objectives. Prior to this role, Scott served as Principal Consultant at Blue Fin Group, specializing in market access and commercialization strategies from September 2018 to January 2021. Scott's extensive experience includes over 15 years at Eli Lilly and Company, where roles included Director of Market Access for the Oncology Business Unit, responsible for product launch strategies and account marketing capabilities. Earlier career positions spanned account management and sales roles at Made2Manage Systems and Kewill ERP. Scott Rubin holds a degree from the University of California, Davis.
This person is not in any teams
This person is not in any offices
PRECISIONadvisors
PRECISIONadvisors, a Precision Value & Health team, is a global life sciences consultancy combining cutting-edge strategic and analytic capabilities. We pair best-in-class consulting expertise with hands-on industry and customer experience to guide launch excellence in biopharmaceutical innovation. Our team excels at understanding the ever-changing and complex healthcare market and helping clients solve high-visibility issues such as early pipeline planning, commercialization strategy, pricing and market access strategy, distribution strategy, patient support services design, and product value proposition. Engineered to shift the trajectory, we collaborate across the Precision Value & Health family to seamlessly bring specialized expertise to every junction of the innovation and commercialization continuum. We are currently seeking qualified candidates to join our team. To learn more about opportunities in our US and Europe offices please go to careers.precisiongroupcompanies.com.